thank you KB Mary A
It is a synthetic version of Thymosin Beta-4, a naturally occurring peptide in the human body
The statements made on this website have not been evaluated by the Food & Drug Administration
The traditional endocrinology pathway was designed for complex metabolic disease management, not for the 70+ million Americans who meet clinical criteria for GLP-1 therapy but don't have comorbidities requiring specialist oversight
The FDA accepted it for filing on April 1, and by that announcement Repros had already dropped the brand, calling it its enclomiphene citrate product candidate, formerly known as Androxal. The indication it sought was narrower than anyone remembers, and the FDA wrote it out in full: NDA 207959, enclomiphene citrate 12.5 mg and 25 mg capsules, for the proposed treatment of secondary hypogonadism in fertile men (men with more than 15 million sperm/milliliter (ml)), younger than 60 years of age with a Body Mass Index (BMI) over 25 kilograms (kg)/meters squared (m2) (80 FR 50639)
Zepbound (tirzepatide) the same active ingredient as Mounjaro, was approved in Japan for obesity treatment and launched there in April 2025
